Jackson Creek Investment Advisors LLC Halozyme Therapeutics, Inc. Transaction History
Jackson Creek Investment Advisors LLC
- $315 Million
- Q1 2025
A detailed history of Jackson Creek Investment Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 26,412 shares of HALO stock, worth $1.41 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
26,412
Previous 26,426
0.05%
Holding current value
$1.41 Million
Previous $1.26 Million
33.41%
% of portfolio
0.54%
Previous 0.38%
Shares
10 transactions
Others Institutions Holding HALO
# of Institutions
595Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$939 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$684 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$323 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$208 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$196 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.43B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...